Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival

Sept. 30-Oct. 3, 2018
New York Marriott Marquis
New York, New York

Extended Abstract Submission Deadline: Tuesday, July 17, 2018, 5 p.m. ET
Advance Registration Deadline: Friday, Aug. 10, 2018

We apologize if you experienced technical difficulties while trying to submit an abstract. Because of the systemwide outage of the website on July 16, the deadline to submit and edit abstracts has been extended.

Conference Cochairs
Nina Bhardwaj, Icahn School of Medicine at Mount Sinai, New York, New York
Christoph Huber, Association for Cancer Immunotherapy (CIMT), Mainz, Germany
Elizabeth M. Jaffee, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Guido Kroemer, Centre de Recherche des Cordeliers, Paris, France

Program Committee
Carl G. Figdor, Radboud University Medical Center, Nijmegen, Netherlands
Wolf H. Fridman, Centre de Recherche des Cordeliers, Paris, France
Crystal L. Mackall, Stanford University School of Medicine, Stanford, California
Cornelis J.M. Melief, Leiden University Medical Center & ISA Pharmaceuticals BV, Leiden, Netherlands
Drew M. Pardoll, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Ellen Puré, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania 
Catherine Sautés-Fridman, Centre de Recherche des Cordeliers, Paris, France
Ton Schumacher, Netherlands Cancer Institute, Amsterdam, Netherlands 
Giorgio Trinchieri, National Cancer Institute, Bethesda, Maryland
Özlem Türeci, Ganymed Pharmaceuticals AG, Mainz, Germany
Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, New York
Laurence Zitvogel, Gustave Roussy Cancer Center, Villejuif, France

The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to once again join forces to present the International Cancer Immunotherapy Conference. The program will focus on “Translating Science into Survival” and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy. This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates. 

Visit the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science Into Survival website for more information

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available